Original articleEpidemiology of hepatocellular carcinoma in Finistère Prospective study from June 2002 to May 2003Épidémiologie du carcinome hépatocellulaire dans le département du Finistère. Étude prospective de juin 2002 à mai 2003
References (27)
Hepatocellular carcinoma
J Hepatol
(2000)- et al.
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver
J Hepatol
(2001) - et al.
Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976-1995
J Hepatol
(1998) - et al.
Characteristics of hepatocellular carcinoma in Italy
J Hepatol
(1998) - et al.
Increase in primary liver cancer in the UK, 1979-94
Lancet
(1997) - et al.
Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis
Hepatology
(1996) - et al.
Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis
Hepatology
(2003) - et al.
Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases
Hepatology
(2000) - et al.
Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d’Etude et de Traitement du Carcinome Hepatocellulaire
J Hepatol
(1999) - et al.
Increased incidence of HFE C282Y mutations in patients with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver
J Hepatol
(2000)
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
Gastroenterology
Cancer incidence and mortality in France over the period 1978-2000
Rev Epidemiol Sante Publique
Augmentation de l’incidence du carcinome hépatocellulaire dans les pays occidentaux. Quelles raisons et quelles conséquences?
Gastroenterol Clin Biol
Cited by (12)
Benefits and harms of screening for hepatocellular carcinoma in high-risk populations: systematic review and meta-analysis
2023, Journal of the National Cancer CenterA nationwide study on hepatocellular carcinoma
2020, Cancer EpidemiologyCitation Excerpt :This puts decision for surveillance in the hands of few caretakers which could be the reason for this better surveillance rate on a nationwide basis. An Australian study reported the proportion diagnosed by surveillance to be 35 % [35], and studies from Belgium [36], France [22] and Italy [15] reported 36 %, 28 % and 36 % respectively, which is similar to the results of the current study. Non-cirrhotic HCC patients were two times more likely to be surgical candidates than cirrhotic HCC patients whereas none of them underwent a liver transplant.
The burden of liver disease in Europe: A review of available epidemiological data
2013, Journal of HepatologySurvival improvement in Child-Pugh C cirrhotic patients with hepatocellular carcinoma diagnosed during 1990-2002
2010, Gastroenterologie Clinique et BiologiquePrognosis of advanced hepatocellular carcinoma: Comparison of three staging systems in two French clinical trials
2008, Annals of OncologyCitation Excerpt :In particular, a high standard of follow-up was applied, resulting in a minimal rate of lost to follow-up, a large number of events and an adequate overall statistical power as compared with previous publications. The population of our study is limited to patients with advanced HCC, representing between 60% and 75% of all patients treated in France [25]. They formed a rather homogenous sample not representative of the whole HCC population, limiting conclusions to the palliative setting.